Procedural Advantages of a Novel Drug-Eluting Coronary Stent

University Hospital Heidelberg

Status: Completed

Conditions: Coronary Artery Disease

Treatments: Device: Synergy Stent; Device: Currently common drug-eluting stent (DES)

Study type: Interventional

Funder types: Other

Identifiers

NCT02881216

Synergy Stent

Details and patient eligibility

About

This study sought to compare procedural performance of a new coronary stent generation, that is already available in Germany, with hitherto established current drug-eluting stents.

Enrollment: 814 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• CAD for PCI, consecutive patients

Exclusion criteria

• Age under 18
• Bare Metal Stents or Scaffolds

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

814 participants in 2 patient groups

Common DES

Other group

Description:

Group of Patients with narrowed coronary artery disease, who were treated with an implantation of currently established drug-eluting stents (Xience Prime, Promus Element plus, Resolute Integrity).

Treatment:

Device: Currently common drug-eluting stent (DES)

Synergy Stent

Other group

Description:

Group of Patients with narrowed coronary artery disease, who were treated with Synergy stent implantation

Treatment:

Device: Synergy Stent